Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Catheterisation using lignocaine gel

  • Comment

VOL: 96, ISSUE: 41, PAGE NO: 43

RAY ADDISON, NURSE CONSULTANT IN BLADDER AND BOWEL DYSFUNCTION, MAYDAY HEALTHCARE NHS TRUST, CROYDON

The use of gel containing 2% lignocaine for catheterisation aims to make catheterisation for both males and females as pain-free as possible.

The use of gel containing 2% lignocaine for catheterisation aims to make catheterisation for both males and females as pain-free as possible.

The rationale for the use of 2% lignocaine gel for catheterisation is not well-founded.

It is important to follow the UKCC (1992) guidelines on the administration of medicines, and local policy.

Nursing assessment prior to administration should identify patients at increased risk of the systemic effects of lignocaine. These include liver disease, epilepsy, hypotension, cardiac problems, pregnancy and the debilitated or frail patient. The dosage (amount) used should be reduced in the elderly and in children.

Lignocaine gel in general is safe when used topically and is unlikely to cause side-effects.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs